(Q40410241)

20 September 2017

1 reference

title

Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis? (English)

1 reference

20 September 2017

Sternberg CN

1

1 reference

20 September 2017

Raghaven D

2

1 reference

20 September 2017

Ohi Y

3

1 reference

20 September 2017

Bajorin D

4

1 reference

20 September 2017

Herr H

5

1 reference

20 September 2017

Kato T

6

1 reference

20 September 2017

Kuroda M

7

1 reference

20 September 2017

Logothetis CH

8

1 reference

20 September 2017

Scher H

9

1 reference

20 September 2017

Splinter TA

10

1 reference

20 September 2017

1 June 1995

1 reference

International Journal of Urology

20 September 2017

1 reference

20 September 2017

2 Suppl 2

1 reference

20 September 2017

76-88

1 reference

Staging invasive bladder tumors

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.1995.TB00482.X

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.1995.TB00482.X

Oral piritrexim, an effective treatment for metastatic urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.1995.TB00482.X

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.1995.TB00482.X

Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.1995.TB00482.X

ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.1995.TB00482.X

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.1995.TB00482.X

Metastasis suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.1995.TB00482.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.1995.TB00482.X

10.1111/J.1442-2042.1995.TB00482.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference